cancer



Radiation Therapy

In prostate cancer treatment, radiation therapy targets high-energy rays or particles in order to kill cancer cells.

Radiation could be used as the initial treatment for low-grade cancer or for advanced cancer that has only spread to nearby tissue. This kind of therapy could also be used if the cancer is not completely removed or is recurrent after surgery. Radiation may also be used to reduce the size of tumors in case of more advanced cancers.

There are two main types of radiation therapy used: external beam radiation (EBRT) and internal radiation (brachytherapy), both appearing as good methods to fight prostate cancer without pain.

cancer

External Beam Radiation Therapy (EBRT)

This method focuses the prostate gland from a x-ray source external of the body using a computer-aided external beam. Before starting the treatment is necessary the exact location of prostate gland in order to guide the maximum radiation in the right area. Each session lasts only few minutes, 5 days per week, over a period of 7 to 9 weeks.

Intensity Modulated Radiation Therapy (IMRT) is a newer form of this radiotherapy. It sends out concentric beams of radiation, like an onion skin, focusing the highest dose in the middle of the tumour and the lowest dose at the edge of the prostate.

Possible EBRT side effects

Newer EBRT techniques decrease the radiation exposure, allow doctors to be more accurate and appear to offer better chances of increasing the success rate and reducing side effects.

  • Bowell problems You may have diarrhea, sometimes with blood in the stool, rectal leakage, and an irritated large intestine. Most of these problems go away over time.
  • Bladder problems The need to urinate often, a burning sensation while urinating and blood in your urine will go away once treatment is over.
  • Urinary incontinence: Less common than after surgery overall, incontinence goes up each year for several years after treatment.
  • Impotence: Different from surgery, it usually does not occur right after radiation therapy but slowly develops over a year or more. About 3 out of 4 men were impotent within 5 years of having old EBRT procedure. It's not clear if these figures will apply to newer radiation methods as well.
  • Lymphedema: Fluid buildup in legs or genitals is possible if the lymph nodes receive radiation.
  • Feeling tired: Possible caused tiredness disappear until a few months after treatment stops.

    Brachytherapy (Internal Radiation Therapy)

    Also called seed implantation or interstitial radiation therapy Brachytherapy is the use of small radioactive "seeds," each about the size of a grain of rice, that are placed directly into prostate. Brachytherapy is generally used only in men with early stage prostate cancer that is slow growing

    Brachytherapy may not be as effective in men with large prostate glands because they need too many seeds. The risk of urinary side effects may be higher in men with transurethral resection of the prostate (TURP) or for those who already have urinary problems.

    Possible risks and side effects of brachytherapy

    The small implanted seeds will give off small amounts of radiation for several weeks, so your doctor may advise you to stay away from pregnant women and small children or wearing a condom during sex. You may also be asked to strain your urine for the first week as some of the seeds may move (migrate). There are very rare reports of the seeds moving through the bloodstream to other parts of the body but this doesn't seem to cause any ill effects.

    Like EBRT, brachytherapy can also cause impotence, urinary problems, and bowel problems.

  • Bowel problems: Significant long-term bowel problems occur in less than 5% of patients.
  • Urinary problems: Despite is not a common side effect, frequent urination caused by irritation of the urethra may persist in about 1 out of 3 patients who have brachytherapy
  • Impotence: Erectile problems may be less likely to develop after brachytherapy, but other studies have found that the impotence rates were no lower than with EBRT or surgery.


    Latest News

  • Arc radiotherapy treatments: Breakthrough in image-guided targeting of prostate tumors
    Researchers at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark), partially supported by Varian Medical Systems (NYSE: VAR), have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. [ read full article ]

  • Decline in sexual function after radiation therapy for prostate cancer
    One of the most concerning problem for patients in the treatment of prostate cancer is erectile dysfunction. The inconsistent evaluation of sexual function (SF) and limited follow-up data request additional study to clarify the rate and timing of erectile dysfunction after external beam radiotherapy (EBRT) for prostate cancer. [ read full article ]

  • Changes in sexual function on mood and quality of life in patients undergoing radiation therapy for prostate cancer
    A new study at Sutter Roseville Medical Center, Roseville, CA, USA, aimed to evaluate the percentages of men with and without changes in sexual function from the beginning to end of radiation therapy. The study also evaluated differences in demographic and clinical characteristics, ... [ read full article ]

  • Sexual function does not decline in prostate cancer patients receiving external beam radiation therapy
    According to a recent study sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first two years after treatment but then stabilizes and does not continuously decline as was previously thought. [ read full article ]

  • Report on the global market for prostate cancer therapeutics
    Reportlinker.com announces that a new market research report is available in its catalogue: Prostate Cancer Therapeutics - A Global Market Perspective. [ read full article ]

  • prostate cancer patients treated with CyberKnife Radiosurgery
    The global leader in the field of radiosurgery, Accuray Incorporated (Nasdaq: ARAY), announced today publication of results from a study of early stage prostate cancer patients treated with CyberKnife Radiosurgery. [ read full article ]

  • Advances in external beam radiotherapy for treatment prostate cancer
    In the past year or so there have been three significant technological advances in the use of external beam radiotherapy for the treatment of localized prostate cancer. It is about CyberKnife Radiotherapy, RapidArc Radiotherapy and Calypso system. [ read full article ]

  • Radiation helps prostate cancer survival
    Men with locally advanced prostate cancer will survive substantially longer when radiation is added to their treatment plan, Swedish researchers said. [ read full article ]

  • Obese Prostate Cancer Patients May Benefit More From Brachytherapy
    Brachytherapy, also called seed implants, may be a more beneficial treatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients.
    [ read full article ]

  • Radiation treatment for cancer after radical prostatectomy linked with increased survival
    Preliminary findings indicate that for men who underwent radical prostatectomy, radiation treatment after prostate cancer recurrence was associated with an increase in prostate cancer-related survival. [ read full article ]



    [ read more articles ]



    NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment.





    • Tell a Friend

    Your Name:
    Friend's Name:
    Friend's Email:
    copyright © 2010 | radiation therapy in prostate cancer treatment